Table 2.
Comparison of relevant indicators between the successful splenic vessel preservation group and the failed splenic vessel preservation group in the modeling group
| Factor | Successful splenic vessel preservation group (n = 98) | Failed splenic vessel preservation group (n = 20) | Statistic | P |
|---|---|---|---|---|
| Age (years), M (Q1, Q3) | 47 (35, 56.25) | 48 (40, 65.75) | Z = −0.73 | 0.46 |
| BMI (kg/m2), M (Q1, Q3) | 24.90 (23.50, 26.75) | 24.31 (21.74, 27.67) | Z = −0.65 | 0.51 |
| Gender, n (%) | χ2 = 0.001 | 0.98 | ||
| Male | 34 (34.7) | 7 (35) | ||
| Female | 64 (65.3) | 13 (65) | ||
| History of hepatitis B, n (%) | χ2 = 0.73 | 0.39 | ||
| None | 88 (89.8) | 16 (80) | ||
| Yes | 10 (10.2) | 4 (20) | ||
| Cirrhosis, n (%) | χ2 = 0.00 | 1.00 | ||
| None | 91 (92.9) | 18 (90) | ||
| Yes | 7 (7.1) | 2 (10) | ||
| Smoking history, n (%) | χ2 = 0.001 | 0.98 | ||
| None | 90 (91.8) | 19 (95) | ||
| Yes | 8 (8.2) | 1 (5) | ||
| Drinking history, n (%) | χ2 = 0.00 | 1.00 | ||
| None | 90 (91.8) | 18 (90) | ||
| Yes | 8 (8.2) | 2 (10) | ||
| Diabetes, n (%) | χ2 = 0.29 | 0.59 | ||
| None | 90 (91.8) | 17 (85) | ||
| Yes | 8 (8.2) | 3 (15) | ||
| History of pancreatitis, n (%) | χ2 = 0.00 | 1.00 | ||
| None | 92 (93.9) | 19 (95) | ||
| Yes | 6 (6.1) | 1 (5) | ||
| History of abdominal surgery, n (%) | χ2 = 0.00 | 1.00 | ||
| None | 94 (95.9) | 19 (95) | ||
| Yes | 4 (4.1) | 1 (5) | ||
| White blood cell count (× 109/L), M (Q1, Q3) | 5.53 (4.58, 6.66) | 5.34 (4.76, 6.79) | Z = −0.48 | 0.63 |
| Neutrophil ratio (%), M (Q1, Q3) | 55(49.55, 62.40) | 55.80 (50.58, 62.67) | Z = −0.50 | 0.62 |
| Hemoglobin (g/L), M (Q1, Q3) | 132 (126.75, 141) | 138 (121.50, 143.75) | Z = −0.47 | 0.64 |
| Total bilirubin (μmol/L), M (Q1, Q3) | 12.79 (10.24, 15.91) | 12.46 (9.61, 15.16) | Z = −0.63 | 0.53 |
| Albumin (g/L), M (Q1, Q3) | 42.22 (39.83, 44.54) | 42.19 (40.64, 45.30) | Z = −0.32 | 0.75 |
| HDL (mmol/L), mean ± SD | 1.37 ± 0.29 | 1.41 ± 0.30 | t = −0.51 | 0.61 |
| LDL (mmol/L), mean ± SD | 3.05 ± 0.93 | 2.95 ± 0.65 | t = 0.46 | 0.65 |
| Platelet (× 109/L), mean ± SD | 230.49 ± 50.89 | 245.85 ± 59.42 | t = −1.20 | 0.23 |
| ASA score, n (%) | χ2 = 0.00 | 1.00 | ||
| Grade 1 | 84 (85.7) | 17 (85) | ||
| Grade 2 | 14 (14.3) | 3 (15) | ||
| Tumor location, n (%) | χ2 = 49.26 | < 0.05 | ||
| Body | 92 (93.9) | 5 (25) | ||
| Tail | 6 (6.1) | 15 (75) | ||
| Tumor volume (mm3), M (Q1, Q3) | 5996.42 (2950.52, 12,677.75) | 22,545.140 (12,633.86, 53,972.33) | Z = −5.62 | < 0.05 |
| TG (mmol/L), M (Q1, Q3) | 0.96 (0.75, 1.39) | 1.16 (0.94, 1.51) | Z = −1.56 | 0.12 |
| TC (mmol/L), M (Q1, Q3) | 5 (4.20, 5.71) | 4.74 (4.04, 5.42) | Z = −0.66 | 0.51 |
| Maximum tumor diameter (cm), M (Q1, Q3) | 3 (2, 4) | 3 (2.50, 4.53) | Z = −1.30 | 0.19 |
| Ratio of SV length embedded in pancreas, M (Q1, Q3 | 0.20 (0.14, 0.31) | 0.18 (0.13, 0.24) | Z = −0.50 | 0.62 |
| Ratio of SV circumference embedded in pancreas, M (Q1, Q3) | 0.24 (0.08, 0.44) | 0.38 (0.31, 0.58) | Z = −5.81 | <0.05 |
| Pancreas–SV contact area (mm2), mean ± SD | 272.40 ± 156.91 | 693.89 ± 374.37 | t = −4.95 | <0.05 |
| Minimum distance between tumor and blood vessel (mm), M (Q1, Q3) | 1.66 (0.72, 5.84) | 0.91 (0.68, 1.53) | Z = −1.35 | 0.18 |
| Ratio of SA length embedded in pancreas, M (Q1, Q3) | 0.16 (0.09, 0.23) | 0.17 (0.08, 0.23) | Z = −0.05 | 0.96 |
| Ratio of SA circumference embedded in pancreas, M (Q1, Q3) | 0.12 (0.08, 0.15) | 0.14 (0.06, 0.15) | Z = −0.21 | 0.84 |
| Pancreas–SA contact area (mm2), M (Q1, Q3) | 131.80 (79.29, 186.06) | 107.29 (67.44, 164.69) | Z = −1.11 | 0.27 |
| Number of collateral branches of SV on pancreatic surface, M (Q1, Q3) | 3 (2, 4) | 3.5 (2, 4) | Z = 0.00 | 1.00 |
| Number of collateral branches of SA on pancreatic surface, M (Q1, Q3) | 2 (1, 3) | 2 (1, 3.75) | Z = −1.22 | 0.22 |
| Maximum curvature of SV (°), M (Q1, Q3) | 107.86 (95.75, 119.26) | 99.93 (90.96, 113.32) | Z = −1.32 | 0.19 |
| Tumor type, n (%) | χ2 = 0.02 | 0.89 | ||
| Solid | 31 (31.6) | 6 (30.0) | ||
| Cystic | 67 (68.4) | 14 (70.0) |